David Blair is a Professor at James Cook University, specializing in parasitic flatworms, molecular systematics, and evolutionary biology. His research focuses on understanding the genetic diversity, phylogeography, and host-parasite interactions of species such as Schistosoma, Paragonimus, and Opisthorchis. He has contributed extensively to studies on the molecular evolution of parasitic organisms and their implications for human and wildlife health. Key research areas include: molecular taxonomy of trematodes, phylogenetic analysis of parasitic flatworms, and genomic studies of host-parasite coevolution. Collaborations span global institutions, addressing public health challenges like paragonimiasis and fasciolosis. His work integrates field studies, lab-based molecular techniques, and computational biology to unravel evolutionary dynamics and ecological adaptations. Recent studies focus on the genetic diversity of Daphnia species, dugong population genetics, and drug-resistant Mycobacterium tuberculosis. His publications in journals like *Parasitology*, *Molecular Phylogenetics and Evolution*, and *Scientific Reports* highlight interdisciplinary approaches to parasitology and conservation biology.
Sophie Dove is an Honorary Associate Professor at the School of Biological Sciences , University of Queensland, and an Affiliate Associate Professor at the Global Change Institute . Her research focuses on coral reef photobiology, climate change impacts, and symbiotic relationships in marine ecosystems. PhD in Biological Sciences, University of Sydney MA in Philosophy, University of Southern California MA (Hons) in Mathematics and Philosophy, University of Edinburgh Her work examines coral-dinoflagellate symbiosis , particularly how host and symbiont interactions maintain reef productivity under climate stress. Key questions include the role of symbiont parasitism, coral heterotrophy, and reef accretion-erosion balance under ocean acidification and warming. She collaborates with institutions like the Great Barrier Reef Marine Park Authority and CSIRO Publishing. Recent publications span coral bleaching mechanisms , ocean acidification effects , and biochemical adaptations in symbiotic organisms. Her studies integrate molecular biology, biogeochemistry, and ecophysiology to predict reef futures under climate stress. She has contributed to scientific consensus reports on the Great Barrier Reef and developed methodologies for analyzing coral and sponge physiology. Her interdisciplinary approach bridges marine ecology, protein biochemistry, and climate science.
Matthew D. Barrett is a researcher at James Cook University , specializing in plant systematics and fungal taxonomy. His work spans diverse areas including angiosperm phylogenomics, fungal biodiversity, and conservation biology of rare Australian flora. Research Focus : Phylogenomic analysis, fungal systematics, and ecological adaptations of Australian plant species. Publications : Contributed to major studies in Nature , Studies in Mycology , and Telopea , with a particular emphasis on Western Australian endemics. His recent publications highlight integrative approaches combining morphological and molecular data for taxonomic revisions, particularly in Basidiomycota and Orchidaceae.
Professor Nick Paul is a marine scientist at the University of the Sunshine Coast (UniSC), leading applied research in seaweed and algae for sustainable product development. He holds a PhD and BSc (Hons) from UNSW and a Graduate Certificate in Tertiary Education Management from the University of Melbourne. His work focuses on seaweed aquaculture innovations, including waste-to-resource biotechnology, functional foods, and environmental remediation. He leads international projects funded by organizations like ACIAR, CSIRO, and Advance Queensland. Research interests include seaweed-based solutions for livestock health, wastewater treatment, and sustainable aquaculture expansion near the Great Barrier Reef. He has pioneered commercial land-based seaweed farming and developed intellectual property in this field. Awards include the 2015 UNAA World Environment Day Award for Sustainable Water Management and the 2015 Queensland Water Innovation Forum Best Paper. He serves on the Asian Fisheries Society Council and Fiji’s National Seaweed Taskforce. Key publications span seaweed cultivation methods, marine genomics, and socio-economic impacts of aquaculture in the Pacific. Grants total over A$3.7 million for projects like diversifying Pacific Island seaweed industries and improving Indonesian seaweed production.
Dr Farhad Masoomi-Aladizgeh is a Research Fellow in the School of Life and Environmental Sciences at the University of Sydney. His work focuses on understanding how environmental stresses like heat and drought impact crop fertility, particularly in cereal crops. He holds a BSc, MSc, and PhD in Plant Biology. His research emphasizes male reproductive systems in plants and seeks to identify molecular mechanisms underlying abiotic stress susceptibility to enhance climate resilience in crops. Education includes advanced training in plant sciences, with a focus on molecular biology and stress physiology. Current research projects explore transcriptome responses to stress, stress tolerance gene identification in crop relatives, and ABA-mediated stress protection in rice. His publications span plant proteomics, stress physiology, and molecular protocols, with a strong emphasis on drought and heat tolerance mechanisms. Notable work includes developing universal nucleic acid isolation protocols and analyzing stress responses in rice and cotton. No scientific awards are listed, but his contributions to crop resilience research are significant. He advises no current students but collaborates on interdisciplinary projects involving genomic and proteomic approaches to agricultural challenges. Research is centered at the University of Sydney with potential collaborations in plant science labs focused on environmental stress mitigation strategies.
Dr. Holger Scheib is an Honorary Associate Professor in the School of the Environment at The University of Queensland. His research focuses on venom evolution, toxinology, and biomedical applications, particularly in reptiles, cnidarians, and other venomous organisms. He collaborates extensively with international researchers on projects involving venom structure-function relationships, evolutionary biology, and clinical implications of venom variation. Research interests span venom evolution, toxin structure and function, and their applications in biomedical contexts. He investigates venom diversity across species, including reptiles, sea anemones, and cnidarians, focusing on how these toxins interact with biological systems. His work also explores the intersection of venom components with allergens and their structural similarities, contributing to a deeper understanding of venom’s ecological and medical significance. His recent publications highlight advancements in understanding venom evolution, toxin structures, and clinical implications. Studies include comparisons of venom proteins with allergens, analyses of venom variation in rattlesnakes, and investigations into the molecular mechanisms of bacterial secretion systems. These works contribute to both basic biological research and potential applications in medicine and biodiscovery. No scientific awards or grants are explicitly mentioned in the provided text. Dr. Scheib’s research is primarily conducted through collaborations within the School of the Environment and international academic networks. No specific lab or team affiliations are detailed.
Claire O'Brien is an Associate Professor in Biomedical Science (Virology) at the University of Canberra, leading the Host-Microbe Interactions research group. Previously, she held positions at the Australian National University (ANU) Medical School as a Lecturer and Senior Lecturer at the University of Wollongong. She earned her PhD from ANU in 2012, focusing on microbiological aspects of Crohn's disease. Her research investigates gut microbiome dysbiosis in diseases like inflammatory bowel disease (IBD), using in vitro co-cultures of bacteria and macrophages. Key projects include studying antimicrobial resistance in retail meat and microbial resilience in IBD patients. Dr. O'Brien has received prestigious awards, including the Australian Academy of Science France-Australia Fellowship and NHMRC Peter Doherty Biomedical Research Fellowship. Her work spans translational research, such as the 'GUTSY' project addressing sarcopenia in Crohn’s disease, and collaborations on microbiome dynamics. She actively supervises Honours and higher-degree research students in IBD and microbiome-related fields. Research interests include host-microbe interactions, Crohn's disease pathogenesis, and the role of the microbiome in health. Her lab employs genomic, transcriptomic, and microbiological techniques to uncover mechanisms linking microbial imbalances to disease. She is also engaged in public health initiatives, such as optimizing preconception care and reducing pregnancy complications in women with polycystic ovary syndrome (PCOS).
Carlos Salomon Gallo is a Professor and NHMRC Investigator Fellow (EL2) at The University of Queensland's Centre for Clinical Research, affiliated with the School of Biomedical Sciences. He directs the Centre for Extracellular Vesicle Nanomedicine and leads the Exosome Biology Laboratory. A globally recognized key opinion leader in extracellular vesicles (ranked 3rd worldwide by Expertscape), his research focuses on EV biology for diagnostic and therapeutic applications in ovarian cancer, gestational diabetes, preeclampsia, and other obstetrical syndromes. His research integrates proteomics (SWATH-MS), miRNA analysis, and advanced isolation techniques to develop liquid biopsies. Core interests include: EV biomarker discovery and validation for early disease detection. Mechanisms of EV-mediated signaling in metabolic and oncological pathologies. Engineering EVs for targeted drug delivery and CRISPR-Cas therapeutics. Clinical translation of EV-based diagnostics (IVDs) and therapeutics. Analysis of his recent articles reveals a dominant focus on EV profiling in pregnancy complications (gestational diabetes, preeclampsia) and oncology (ovarian cancer), utilizing multi-omics approaches. Key trends include developing high-sensitivity EV biosensors, understanding hypoxia-induced EV signaling, and exploring 3D models for EV research. He has received significant recognition, including: NHMRC Emerging Leadership Fellow NHMRC Investigator Fellow (EL2) He leads the Exosome Biology Laboratory and the UQ Centre for Extracellular Vesicle Nanomedicine, fostering cross-disciplinary collaboration. His work involves extensive national and international partnerships, evidenced by leadership roles in the Centre for Clinical Diagnostics and over 20 invited international talks in 5 years. He actively mentors HDR students and contributes to global EV research standards (MISEV2023).
Fabio Zanini is an Associate Professor at the University of New South Wales (UNSW) , leading a research group focused on computational biology , single-cell approaches , and transcriptomic analysis across diseases like severe dengue , neonatal lung disease , cancer , and marine biology . He previously conducted postdoctoral research at Stanford University (2016-2019) and earned a PhD in Bioinformatics from the Max Planck Institute for Developmental Biology and the University of Tuebingen (2015). Current Affiliation: Group leader, UNSW Previous Training: Postdoc (Stanford), PhD (Max Planck/University of Tuebingen) His research spans single-cell RNA sequencing , computational virology , developmental cell biology , and bioinformatics tool development , with recent work on: Severe dengue progression (viral-host interactions, immune signatures) Lung development (endothelial cell diversity, hyperoxia-induced injury) Cancer genomics (mutant HSC clones, AZA therapy response) Marine biology (plankton transcriptomics, evolutionary analysis) Bioinformatics (HTSeq 2.0, northstar algorithm) Recent scientific awards include grants from the Chan Zuckerberg Initiative ($270,000), NIH R01 (multiple), ARC Discovery Grant , and NHMRC Ideas Grant . Notable contributions include: Northstar - Cell classification algorithm SpectralSeq - Hyperspectral-transcriptomic integration Tabula Muris - Mouse aging atlas He has supervised research into hematopoietic stem cell regulation , lung vascular development , and autophagy in viral infections , with collaborations across Stanford , University of Sydney , and Harvard .
Dr. Zhi-Ping Feng is a Bioinformatician at the John Curtin School of Medical Research (JCSMR), Australian National University (ANU). Her research focuses on integrating omics data with protein structure-function relationships to study interactions between macromolecules. She has expertise in analyzing genomic and transcriptomic data (e.g., RNA-Seq, ChIP-Seq) and protein structure determination via nuclear magnetic resonance (NMR) spectroscopy. Previously, she held a Senior Research Fellow position at the Walter and Eliza Hall Institute (WEHI) from 2009, working on quality control in omics research and genomic data analysis. Her postdoctoral work at WEHI (2002–2005) involved structural biology of malaria-related proteins, supported by an Australian Postdoctoral Fellowship. She holds a PhD in protein bioinformatics from China and a physics background from Peking University. Education: PhD in Protein Bioinformatics (China) Bachelor’s in Physics, Peking University Research Interests: Her work bridges computational biology and structural biology, with emphasis on: Intrinsically unstructured proteins (IUPs) and their applications in malaria proteomics Omics data integration for disease modeling (e.g., cancer, diabetes, neurodegeneration) Protein-protein interaction networks and structural bioinformatics Publications: Recent work spans cancer immunotherapy, miRNA regulation in retinal degeneration, and T cell biology, with contributions to understanding Wnt signaling in joint replacement complications and genetic fusions in pediatric brain tumors. Awards: Australian Postdoctoral Fellowship (2005) Grants/Teams: Currently affiliated with ANU Bioinformatics Consultancy, supporting translational medical research in immunology, cancer, and genomics. Labs/Teams: Collaborates with the JCSMR’s multidisciplinary teams focusing on biomedical informatics and translational research.
Senani N.H. Rathnayake is a Research Fellow at the University of Technology Sydney (UTS), Faculty of Science. He completed his PhD at UTS (2019-2024) and held a Postdoctoral Fellowship at the University of Groningen (2023-2024). His primary research focuses on respiratory diseases, particularly the molecular mechanisms of smoking-induced lung damage, COPD, and asthma. Key areas include gene expression profiling, epigenetic changes, and cellular responses to cigarette smoke exposure. Research Interests: Transcriptomic and epigenetic alterations in lung diseases Smoking cessation effects on airway biology Genetic regulation of COPD biomarkers (e.g., sRAGE) Sex chromosome influences on respiratory disease susceptibility Awards & Fellowships: 2023 TSANZ Past Presidents Scholarship Award 2022-2023 European Respiratory Society Short-Term Fellowship Recent Research Trends: His articles emphasize smoking's impact on bronchial epithelial cells, including transcriptomic shifts, mucus barrier dynamics, and CRISPR-based gene-editing applications. Recent work explores Y-chromosome effects on COPD and asthma pathogenesis. Professional Engagement: Co-chair of the 2023 TSANZ Annual Scientific Conference Member of Australian Society for Medical Research, European Respiratory Society, and Thoracic Society of Australia and New Zealand
Dr. Premdass Ramdas is a Senior Lecturer at Monash University Malaysia, affiliated with the Jeffrey Cheah School of Medicine and Health Sciences. He joined in October 2023 with over 13 years of experience in medical biotechnology and health sciences, focusing on cancer research and bioactive natural compounds. PhD in Cancer Proteomics and Genomics, University of Malaya MSc in Medical Sciences (Cancer Genomics and Natural Products), International Medical University BSc with First-Class Honors His research focuses on the anticancer mechanisms of tocotrienols, utilizing proteomics, genomics, bioinformatics, and mouse models. He explores epigenetics, nutrigenomics, RNA/microRNA analysis, exosome biology, and AI-driven big data in cancer. His work contributes to UN Sustainable Development Goals in health and well-being. Recent publications show a strong trend in systematic reviews and mechanistic studies on vitamin E analogues in cancer, particularly colorectal and breast cancers. His research integrates molecular biology with computational approaches, including molecular docking and data mining. First-class honors for BSc Malaysian Palm Oil Board Scholarship for MSc MyBrain15 Scholarship for PhD Dr. Ramdas has secured research grants such as FRGS and actively supervises research projects. He is currently accepting PhD students and has co-supervised non-HDR reviews, indicating active mentorship. He has no known labs or teams explicitly mentioned, but collaborates extensively, particularly with Prof. Radhakrishnan A.K.
Andrew Currie is a Professor and Associate Dean (Research & Innovation) at Murdoch University's School of Medical, Molecular and Forensic Sciences, within the College of Environmental and Life Sciences. He leads the Sepsis Diagnostics Research Group at the Centre for Molecular Medicine and Innovative Therapeutics and co-heads the Neonatal Infection and Immunity Team with Clinical Professor Tobias Strunk at the Wesfarmers Centre of Vaccine & Infectious Diseases at Telethon Kids Institute. His research focuses on immunology and infectious diseases in pediatric populations, particularly sepsis diagnostics and neonatal immunity. Education: PhD (Immunology, University of Western Australia, 2001); BSc (Biotechnology with Honors, Murdoch University, 1997). Research Interests: Sepsis diagnostics, innate immunity mechanisms in neonates, medical biotechnology for diagnostics (e.g., biosensors), and translational research in pediatric infections. Collaborates internationally with institutions in Canada, Denmark, the UK, US, and China. Aims to reduce sepsis burden in vulnerable populations through advanced molecular methods and interdisciplinary partnerships. Key Affiliations: Lead of Sepsis Diagnostics Research Group (Murdoch University), Senior Lecturer in Immunology, Honorary Associate at Kids Research Institute Australia. Past roles include leadership in the Centre for Molecular Medicine and Innovative Therapeutics. Scientific Contributions: Over 100 peer-reviewed articles focusing on sepsis biomarkers, neonatal immunity, tick-borne diseases, and clinical trials for interventions like vitamin C and probiotics in critical illness. Active in developing precision medicine approaches for neonatal sepsis. Grants & Funding: Co-leads major projects on sepsis diagnostics and neonatal infection, supported by national and international grants. Collaborates on multi-institutional initiatives. Labs/Teams: Sepsis Diagnostics Research Group (Murdoch) and Neonatal Infection and Immunity Team (Telethon Kids Institute). Works closely with the Personalised Medicine Centre and Health Futures Institute.
Dr. Sheng-Jian Ji is a Tenured Associate Professor at the School of Life Sciences, Department of Neuroscience at Southern University of Science and Technology (SUSTech) in Shenzhen, China. He also serves as the Academic Vice President of Shude Academy and was previously the first Deputy Director of Research and Graduate Affairs in the Department of Biology at SUSTech (2016-2018). As a leading neuroscientist specializing in RNA modification and neural development, Dr. Ji has established an internationally recognized research program. Dr. Ji's educational background includes: 2003-2007: Postdoctoral Fellow, Johns Hopkins University School of Medicine, Neurobiology 1998-2003: PhD in Biochemistry and Molecular Biology, Peking University School of Life Sciences 1994-1998: Bachelor's Degree in Biochemistry, Yantai University Department of Biochemistry Dr. Ji's research primarily focuses on developmental neurobiology, with particular emphasis on post-transcriptional regulation mechanisms including RNA modification and local translation of mRNA in axons. His laboratory is recognized as one of the leading international groups studying how mRNA modification (particularly m6A and m5C) regulates neural development and function. Through innovative approaches combining molecular biology, cell biology, and microfluidic technologies, his team has revealed important insights into axon growth, dendrite maintenance, cortical neurogenesis, and retinal development. His publication record shows a clear trajectory from fundamental mechanisms of RNA modification to applications in understanding neurological disorders and aging. Recent work has expanded into aging-related neural decline, cognitive functions, and potential therapeutic targets for neurological conditions. Dr. Ji has received numerous prestigious awards: 2020, 2016: SUSTech Excellent College Mentor 2020: SUSTech Biology Department Outstanding Service Award 2019: Guangdong Province Talent Youyue Card A 2017: Guangdong Provincial Professor of Neurobiology 2013: Jiangsu Distinguished Professor (Nanjing University) 2011: National Natural Science Award Second Prize (third contributor) As an educator, Dr. Ji teaches undergraduate Neurobiology and graduate Cellular and Molecular Neurobiology courses. He actively mentors students, with recent master's graduates including Yuan Jiaxin and Zhang Pingrui. His laboratory recruits postdoctoral fellows (with salaries of 335,000+ RMB annually), research assistants, and graduate students, providing comprehensive training in molecular techniques, neuronal cell culture, microfluidics, and omics approaches. Dr. Ji leads a vibrant research team that collaborates both within SUSTech and internationally. His work continues to advance understanding of RNA modification in neural development, function, and aging, with recent progress highlighted in June 2025.
Professor Jinman Kim is a Professor in the School of Computer Science at the University of Sydney and Director of the Biomedical Data Analysis and Visualisation (BDAV) Lab. He also serves as Research Director of the Telehealth and Technology Centre at Nepean Hospital. His research focuses on machine learning applications in biomedical image analysis, visualization, and multi-modal data processing. Kim holds a PhD in Computer Science from the University of Sydney (2006) and has held roles including Senior Lecturer (2013), Associate Professor (2016), and Professor (2022). He is an Area Editor for Computer Methods and Programs in Biomedicine and actively contributes to AI-driven healthcare initiatives. His academic journey includes a Marie Curie Fellowship at the University of Geneva (2010) and leadership roles in projects like the ARC Training Centre in Innovative Biomedical Engineering. He co-leads the Digital Health Imaging initiative under the Faculty of Engineering’s Digital Science Initiative. Kim has developed teaching programs such as the Master of Digital Health and Data Science, co-taught with the Faculty of Medicine and Health. Research interests span AI in medical imaging, telehealth systems, and interdisciplinary biomedical engineering. His work includes advancements in PET/CT fusion, tumor segmentation, and medical visual analytics. Kim’s lab explores applications like AI in dental education, cutaneous lymphoma detection, and fair AI models for healthcare. Notable collaborations include the Telehealth Remote Monitoring System for chronic patients and contributions to datasets like the HRDC Challenge for hypertension classification. His labs prioritize translating AI innovations into clinical tools for improved healthcare accessibility and precision.
